FDA.reportPublic FDA data

30 ML bupivacaine hydrochloride 7.5 MG/ML Injection

RxCUI
1724786
RxNorm name
30 ML bupivacaine hydrochloride 7.5 MG/ML Injection
Display name
BUPivacaine (Injectable)
Full name
30 ML bupivacaine hydrochloride 7.5 MG/ML Injection
Term type
SCD
Status
Active
Strength
7.5 mg/ml
Dose form
Injection 30 ml
Route
Injectable
Updated
2026-10-27 17:48:55

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012016
Active start
012016
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bupivacaine hydrochloride7.5 MG / 1 MLbupivacainebupivacaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bupivacaine1815

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STR30 ML BUPivacaine hydrochloride 7.5 MG/ML Injection1NAMES
RxNorm Name30 ML bupivacaine hydrochloride 7.5 MG/ML Injection1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID
8 linked values
8CODES
RxCUI17247861CODES
MMSL_CODEMTH_RXN_BD149361CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0143-9335-100143-9335Bupivacaine Hydrochloride Bupivacaine HydrochlorideHikma Pharmaceuticals USA Inc.ANDA204842
0409-1165-020409-1165Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDEHospira, Inc.ANDA070585
31722-277-3331722-277BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDECamber Pharmaceuticals, Inc.ANDA217821
31722-277-3431722-277BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDECamber Pharmaceuticals, Inc.ANDA217821
55150-172-3055150-172Bupivacaine Hydrochloride Bupivacaine HydrochlorideEugia US LLCANDA203895
70594-121-0170594-121Bupivacine HCl Bupivacaine hydrochlorideXellia Pharmaceuticals USA LLCANDA091487
72603-800-2572603-800BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDENorthStar RxLLCANDA217821
83270-167-0183270-167Bupivacaine Hydrochloride Bupivacaine HydrochlorideONESOURCE SPECIALTY PHARMA LIMITEDANDA091487
83854-005-1083854-005Bupivacaine Hydrochloride Bupivacaine HydrochlorideAnthea Pharma Private LimitedANDA220493

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA2048420143-9335Bupivacaine Hydrochloride Bupivacaine HydrochlorideANDAHikma Pharmaceuticals USA Inc.
ANDA0705850409-1165Bupivacaine Hydrochloride BUPIVACAINE HYDROCHLORIDEANDAHospira, Inc.
ANDA21782131722-277BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDEANDACamber Pharmaceuticals, Inc.
ANDA20389555150-172Bupivacaine Hydrochloride Bupivacaine HydrochlorideANDAEugia US LLC
ANDA09148770594-121Bupivacine HCl Bupivacaine hydrochlorideANDAXellia Pharmaceuticals USA LLC
ANDA22049383854-005Bupivacaine Hydrochloride Bupivacaine HydrochlorideANDAAnthea Pharma Private Limited

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 57 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00143933501rxnav_ndcsyes
00143933510rxnav_ndcsyes
00409116502rxnav_ndcsyes
00409116519rxnav_ndcsyes
31722027730rxnav_ndcsyes
31722027733rxnav_ndcsyes
31722027734rxnav_ndcsyes
55150017230rxnav_ndcsyes
70594012101rxnav_ndcsyes
71288072832rxnav_ndcsyes
72603080001rxnav_ndcsyes
72603080025rxnav_ndcsyes
83270016701rxnav_ndcsyes
83854000501rxnav_ndcsyes
83854000510rxnav_ndcsyes
00024121402rxnav_historical_indirect
00024121410rxnav_historical_indirect
00024121430rxnav_historical_indirect
00024122910rxnav_historical_indirect
00074116401rxnav_historical_indirect
00074116501rxnav_historical_indirect
00074116502rxnav_historical_indirect
00074158210rxnav_historical_indirect
00074158229rxnav_historical_indirect
00074158230rxnav_historical_indirect
00074176102rxnav_historical_indirect
00074176162rxnav_historical_indirect
00074361301rxnav_historical_indirect
00074361352rxnav_historical_indirect
00074427401rxnav_historical_indirect
00074562301rxnav_historical_indirect
00074562302rxnav_historical_indirect
00074574701rxnav_historical_indirect
00186102603rxnav_historical_indirect
00186102688rxnav_historical_indirect
00186103701rxnav_historical_indirect
00186103702rxnav_historical_indirect
00186103712rxnav_historical_indirect
00186103792rxnav_historical_indirect
00409116401rxnav_historical_indirect
00409116501rxnav_historical_indirect
00409158210rxnav_historical_indirect
00409158229rxnav_historical_indirect
00409176102rxnav_historical_indirect
00409176162rxnav_historical_indirect
00409361301rxnav_historical_indirect
00409361352rxnav_historical_indirect
00409427401rxnav_historical_indirect
00409562301rxnav_historical_indirect
00409562302rxnav_historical_indirect
00548824300rxnav_historical_indirect
25021066510rxnav_historical_indirect
25021066530rxnav_historical_indirect
55150017110rxnav_historical_indirect
70529000701rxnav_historical
70529000801rxnav_historical
82449022801rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BUPIVACAINE HYDROCHLORIDEBUPIVACAINE HYDROCHLORIDENorthStar RxLLCee3b5bbe-4013-4682-b6ee-db86e77880772026-07-20Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 72603-800-25
ndc (product): 72603-800
ndc11 (package): 72603080001
ndc11 (package): 72603080025
rxcui: 1724786
Marcaine SpinalBUPIVACAINE HYDROCHLORIDE IN DEXTROSEHospira, Inc.9679cc05-2f8a-4e88-53b5-6e9122c8b8c02026-06-23Warnings, Adverse reactionsExact identifier
ndc11 (package): 00409176162
ndc11 (package): 00409176102
Bupivacaine SpinalBUPIVACAINE HYDROCHLORIDE IN DEXTROSEHospira, Inc.7a8d2539-4422-4312-0298-207ef1a2948e2026-04-07Warnings, Adverse reactionsExact identifier
ndc11 (package): 00409361301
BUPIVACAINE HYDROCHLORIDEBUPIVACAINE HYDROCHLORIDECamber Pharmaceuticals, Inc.0e552e3a-cf52-4d74-9381-6cc1b29b4c902026-04-04Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 31722-277-34
ndc (package): 31722-277-33
ndc (product): 31722-277
ndc11 (package): 31722027733
ndc11 (package): 31722027730
ndc11 (package): 31722027734
rxcui: 1724786
Bupivacaine HydrochlorideBUPIVACAINE HYDROCHLORIDEHospira, Inc.02a845c3-4521-4926-e397-25ab536e7cf62026-03-09Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 0409-1165-02
ndc (product): 0409-1165
ndc11 (package): 00409116501
ndc11 (package): 00409116502
ndc11 (package): 00409116519
rxcui: 1724786
Bupivacaine HydrochlorideBUPIVACAINE HYDROCHLORIDEONESOURCE SPECIALTY PHARMA LIMITED5c10e3a1-7806-40c7-afd2-4c420e1418232025-11-28Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 83270-167-01
ndc (product): 83270-167
ndc11 (package): 83270016701
rxcui: 1724786
Bupivacaine HydrochlorideBUPIVACAINE HYDROCHLORIDEEugia US LLCffecf450-1f01-4721-8e10-2513858526122025-05-29Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 55150-172-30
ndc (product): 55150-172
ndc11 (package): 55150017110
ndc11 (package): 55150017230
rxcui: 1724786
Bupivacaine HydrochlorideBUPIVACAINE HYDROCHLORIDEHikma Pharmaceuticals USA Inc.8815c8c6-eed8-4afe-a5c1-44d2194025a32024-04-11Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 0143-9335-10
ndc (product): 0143-9335
ndc11 (package): 00143933510
ndc11 (package): 00143933501
rxcui: 1724786
Bupivacaine HClBUPIVACAINE HYDROCHLORIDEXellia Pharmaceuticals USA LLCf29c905e-9a55-446f-a89d-860ad9ade7ad2023-06-09Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 70594-121-01
ndc (product): 70594-121
ndc11 (package): 70594012101
rxcui: 1724786
SENSORCAINEBUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATEFresenius Kabi USA, LLCbc61a9a6-0a4e-48a9-b908-e5e66b9f23eb2023-04-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1724786

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 13 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
02a845c3-4521-4926-e397-25ab536e7cf6BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]439These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE injection, for infiltration, perineural, caudal, or ep20260309
67578b56-7540-487e-1fba-481255620e78BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]438These highlights do not include all the information needed to use MARCAINE™ and MARCAINE™ WITH EPINEPHRINE safely and effectively. See full prescribing information for MARCAINE™ and MARCAINE™ WITH EPINEPHRINE. MARCAINE™ (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use MARCAINE™ WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, or epidural use Initial U.S. Approval: 197220260529
ffecf450-1f01-4721-8e10-251385852612BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]49These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 197220250529
bc61a9a6-0a4e-48a9-b908-e5e66b9f23ebBUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]47These highlights do not include all the information needed to use SENSORCAINE ® -MPF, SENSORCAINE ® -MPF WITH EPINEPHRINE, SENSORCAINE ® , and SENSORCAINE ® WITH EPINEPHRINE, safely and effectively. See full prescribing information for SENSORCAINE ® -MPF, SENSORCAINE ® -MPF WITH EPINEPHRINE, SENSORCAINE ® , and SENSORCAINE ® WITH EPINEPHRINE. SENSORCAINE ® -MPF (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar use SENSORCAINE ® -MPF WITH EPINEPHRINE (bupiv20230430
4e0cff98-ad0e-494d-8316-b7cdfad6a876BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]45These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 197220260423
8815c8c6-eed8-4afe-a5c1-44d2194025a3BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]44These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 197220240411
85667365-c166-4fd4-a8dc-d0d3340179fcBUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]44Burapren 0.75% Injection System20220222
0e552e3a-cf52-4d74-9381-6cc1b29b4c90BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]43These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 197220260404
290b9588-05a0-457e-bc65-7684eaff4057BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]43Durapren 0.75% Injection System20220222
daec9ee4-b666-485e-a153-4b5e5acc48a1BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]42These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 197220260417
ee3b5bbe-4013-4682-b6ee-db86e7788077BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]42These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 197220251017
f29c905e-9a55-446f-a89d-860ad9ade7adBUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]42These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 197220230609
5c10e3a1-7806-40c7-afd2-4c420e141823BUPivacaine HCl 0.75 % in 30 ML Injection [PSN] · 30 ML bupivacaine hydrochloride 7.5 MG/ML Injection [SCD] · bupivacaine HCl 0.75 % in 30 ML Injection [SY] · bupivacaine HCl 225 MG per 30 ML Injection [SY]41These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural use. Initial U.S. Approval: 197220251128

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
0e552e3a-cf52-4d74-9381-6cc1b29b4c90These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972Camber Pharmaceuticals, Inc. | Aspiro Pharma Limited20260404
02a845c3-4521-4926-e397-25ab536e7cf6These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION and BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE injection, for infiltration, perineural, caudal, or epHospira, Inc. | Pfizer Healthcare India Private Limited20260309
ffecf450-1f01-4721-8e10-251385852612These highlights do not include all the information needed to use BUPIVACAINE HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for BUPIVACAINE HYDROCHLORIDE INJECTION. BUPIVACAINE HYDROCHLORIDE injection, for infiltration, perineural, caudal, epidural, or retrobulbar use Initial U.S. Approval: 1972Eugia US LLC | EUGIA PHARMA SPECIALITIES LIMITED20250529
290b9588-05a0-457e-bc65-7684eaff4057Durapren 0.75% Injection SystemIT3 Medical LLC20220222
27c42bab-2a96-4aca-8fec-e778e2ca8134Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20161018
265665e6-f527-4746-af8d-38ba25110b19Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20161011
0316eedf-e8c1-483a-8d5a-e1bc1282ead5Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20160929
00eb9611-3173-49d2-a81f-164b9244fb87Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20160928
1c48aa77-0021-4628-9def-7f9e4c7bbb7aSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20160802
1c636622-85e2-4455-a20f-ce0102e806a6Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20160427
21283ec3-f1d0-4a35-80d8-f6fc5d30014dSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20160427
11b2f885-b837-455c-8d77-0b38e14e35c3Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20150930
0d8e930c-9709-4540-bde4-8e7039ce3606Smiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd.20150528
1918e831-b2cc-4456-910e-781c12b40418Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20150324
0222f7ec-86ae-474d-ae9a-8ca1b98938a3Smiths Medical ASD, Inc. | Hospira, Inc. | 3M Company20150312
272f30af-1f4a-406b-a23a-0d955ed6a0bbSmiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | 3M Company20140827
27cb8ee8-5cbf-4c43-97f0-5c8c38fd2f64Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20140303
13cb130f-ef0b-4aa6-8fce-4b1f5de922b3Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20131119
09abf090-af04-4381-963d-c88b93c82a21Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20130913
04ed52f2-bd25-413c-9791-053440bd8a85Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20130314
09156429-0163-4819-bfb0-19b412e905cbSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20121203
005bfa1f-b9fd-4d63-a926-515d341667ddSmiths Medical ASD, Inc. | Hospira, Inc. | Kwang Myung Pharm. Co., Ltd. | Aplicare, Inc.20121128
1c700cc5-f3c0-4398-a5cc-12a651996b67Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20121127
2708b5c7-fc57-48af-ab23-ff432c8644ebSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20121023
16bdb142-7760-4603-93ec-ae57125cdce2Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20121001
167936cf-f527-442f-95a4-a76ad2f9f930Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120917
15af6924-29ca-4efc-84f1-7f584db5a86bSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120820
1b822e60-ce74-4117-91a3-6b536f2d3a00Smiths Medical ASD, Inc. | Hospira, Inc.20120807
2228d7fe-9788-4a25-b09d-6a7b49cf7b93National Council for Prescription Drug Programs20120724
1e956e6e-4d80-44d4-985b-227b94eea277Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120723
27049fe9-8144-486e-b54a-66ec5bdef34eSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120717
10161af7-527c-426e-ac8e-c43e4736f2c1Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120625
250644e0-94b7-4da2-821a-50f66b54eb35Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120621
1643ed50-7c75-4df9-bffb-f0353c97e3c2Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120620
213ec9ed-b3b2-4c00-b837-9d4f2a185079Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120618
251e7648-292b-466e-aea0-da484dd7f781Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120521
27a82cef-a75a-4f41-97a1-023f7ba04fc0Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120409
1e1ede8b-30a8-4892-bf7b-a4e1ed1e59f3Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120404
07a6ca28-7a8b-4527-bac6-aa0e72f1ce35Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120301
0d595be4-2a8d-46dd-b230-e5942e3a34b2Smiths Medical ASD, Inc. | Hospira, Inc.20120301

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4bupivacaine
FDASPLD000577AmidesCHEMhas_chemical_structurebupivacaine
FDASPLN0000175682Amide Local AnestheticEPChas_epcbupivacaine
FDASPLN0000175976Local AnesthesiaPEhas_pebupivacaine
MEDRTD002045BupivacaineCHEMhas_ingredientbupivacaine
MEDRTD002045BupivacaineCHEMhas_ingredientbupivacaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withbupivacaine
MEDRTD004342Drug HypersensitivityDISEASEci_withbupivacaine hydrochloride
MEDRTD010146PainDISEASEmay_preventbupivacaine
MEDRTD010146PainDISEASEmay_preventbupivacaine hydrochloride
MEDRTD010149Postoperative PainDISEASEmay_treatbupivacaine
MEDRTD010149Postoperative PainDISEASEmay_treatbupivacaine hydrochloride
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moabupivacaine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moabupivacaine hydrochloride
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabupivacaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabupivacaine hydrochloride
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pebupivacaine
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pebupivacaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pebupivacaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pebupivacaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH7.5 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY30 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA070585
CODESANDAANDA091487
CODESANDAANDA203895
CODESANDAANDA204842
CODESANDAANDA217821
CODESANDAANDA220493
CODESVUID4044090
NAMESPrescribable SynonymBUPivacaine HCl 0.75 % in 30 ML Injection
NAMESTallman Synonym30 ML BUPivacaine hydrochloride 7.5 MG/ML Injection
NAMESTallman SynonymBUPivacaine HCl 0.75 % in 30 ML Injection
NAMESTallman SynonymBUPivacaine HCl 225 MG per 30 ML Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File